Acupath - PRWeb Press Release Group http://www.rsspad.com/rss2/8398.xml Acupath - Powered by PRWeb and RSSPad en xml@emediawire.com xml@emediawire.com 30 'Personalized Medicine' Avances Colon Cancer Treatment Dr. Olga Falkowski on Testing for K-RAS Gene Mutation Helping Pinpoint Individual Therapies http://www.prweb.com/releases/2009/06/prweb2547494.htm A new test for K-RAS gene mutation will help oncologist identify the medicines that will help most. That's the recent conclusion of both the American Society for Clinical Oncology and the National Comprehensive Cancer Network. (PRWeb Jun 19, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2547494.htm

]]> Fri, 19 Jun 2009 07:00:00 GMThttp://www.prweb.com/releases/2009/06/prweb2547494.htm Noninvasive Test for Bladder Cancer May Save Lives http://www.prweb.com/releases/2009/06/prweb2491544.htm Leading-edge researchers excited about test's potential, possibilities. Acupath's Dr. Shashi Pawar on the new test. (PRWeb Jun 4, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2491544.htm

]]> Thu, 04 Jun 2009 07:00:00 GMThttp://www.prweb.com/releases/2009/06/prweb2491544.htm Acupath Soon to Offer "Flaer" Reagent for Diagnosing PNH http://www.prweb.com/releases/2009/04/prweb2362674.htm New Diagnostic Process Identifies Rare Blood Disease More Accurately and Allows for Quicker Treatment (PRWeb Apr 29, 2009)

Read the full story at http://www.prweb.com/releases/2009/04/prweb2362674.htm

]]> Wed, 29 Apr 2009 07:00:00 GMThttp://www.prweb.com/releases/2009/04/prweb2362674.htm Indoor Tanning Remains Appealing, and Deadly, for Millions http://www.prweb.com/releases/2009/04/prweb2262824.htm Long Island Pathologist discusses why Americans continue to use tanning salons. (PRWeb Apr 1, 2009)

Read the full story at http://www.prweb.com/releases/2009/04/prweb2262824.htm

]]> Wed, 01 Apr 2009 07:00:00 GMThttp://www.prweb.com/releases/2009/04/prweb2262824.htm Better Biopsies: Breast Cancer Tests Get Smarter; New Assays Save Time -- and Lives http://www.prweb.com/releases/2009/02/prweb2015974.htm Breast cancer is the second most common cancer among women in the U.S. New treatment options promise longer and healthier lives for breast cancer patients, and new testing methods are helping doctors decide which of these treatments will work best on an individual woman. Doctors now know that cancer cells can develop because of a problem in the genes that are involved in normal cell growth. (PRWeb Feb 12, 2009)

Read the full story at http://www.prweb.com/releases/2009/02/prweb2015974.htm

]]> Thu, 12 Feb 2009 08:00:00 GMThttp://www.prweb.com/releases/2009/02/prweb2015974.htm Screening for Breast Cancer May Soon be Easier http://www.prweb.com/releases/2008/11/prweb1641154.htm According to Dr. Olga Falkowski, Unit Chief of Breast Pathology and the Associate Medical Director of Acupath Laboratories in New York, "New Technologies May Provide More Information Than Standard Screening Tests". (PRWeb Nov 24, 2008)

Read the full story at http://www.prweb.com/releases/2008/11/prweb1641154.htm

]]> Mon, 24 Nov 2008 08:00:00 GMThttp://www.prweb.com/releases/2008/11/prweb1641154.htm HPV Increases Men's Risk for Oral Cancer, Prompts Calls for Vaccine: Pathology Expert Dr. Shashi Pawar on HPV Health Concerns for Men http://www.prweb.com/releases/2008/09/prweb1382044.htm The human papillomavirus is one of the most insidious and dangerous sexually transmitted diseases for women, as it has been linked to a vast majority of cervical cancers. We are now seeing the effects of HPV infection in men, and the marked increase in oral cancer - coupled with the well-known increased risk for penile and anal cancers - suggests that both sexes face equally serious health consequences from this virus. (PRWeb Sep 26, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1382044.htm

]]> Fri, 26 Sep 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/09/prweb1382044.htm Hope on Horizon for Women with Aggressive Form of Breast Cancer http://www.prweb.com/releases/2008/07/prweb1159494.htm The discovery of HER-2 as a differentiating factor in certain breast cancers paved the way for a better understanding of how this particular genetic marker can affect the progress of the cancer itself, and how it influences the cancer's response to certain treatment regimens. Pathology expert on molecular studies that may lead to better survival and cure rates. (PRWeb Jul 31, 2008)

Read the full story at http://www.prweb.com/releases/2008/07/prweb1159494.htm

]]> Thu, 31 Jul 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/07/prweb1159494.htm